Cargando…

Therapeutic approaches to the treatment of recurrent respiratory papillomatosis of the aerodigestive tract (a clinical study)

Recurrent respiratory papillomatosis (RRP) is a rare disease, characterized by recurrent proliferation of benign squamous cell papillomas in the larynx as well as in the other parts of the aerodigestive tract. We have compared different treatment options for RRP of the aerodigestive tract including...

Descripción completa

Detalles Bibliográficos
Autores principales: Avramov, Toma, Vetckova, Evelina, Nikolova, Maria, Valev, Dinko, Manolova, Antoaneta, Tafradgiiska, Maya, Kostadinov, Dimitar, Tchalacov, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648339/
https://www.ncbi.nlm.nih.gov/pubmed/26692782
http://dx.doi.org/10.1080/13102818.2014.933500
_version_ 1782401218532868096
author Avramov, Toma
Vetckova, Evelina
Nikolova, Maria
Valev, Dinko
Manolova, Antoaneta
Tafradgiiska, Maya
Kostadinov, Dimitar
Tchalacov, Ivan
author_facet Avramov, Toma
Vetckova, Evelina
Nikolova, Maria
Valev, Dinko
Manolova, Antoaneta
Tafradgiiska, Maya
Kostadinov, Dimitar
Tchalacov, Ivan
author_sort Avramov, Toma
collection PubMed
description Recurrent respiratory papillomatosis (RRP) is a rare disease, characterized by recurrent proliferation of benign squamous cell papillomas in the larynx as well as in the other parts of the aerodigestive tract. We have compared different treatment options for RRP of the aerodigestive tract including surgical, conservative and combined approaches. A total of 43 patients with papillomatosis that received a combined therapy were followed in the period from 2009 to 2013. The treatment included electrosurgery and CO(2) laser surgery alongside with either immunotherapy with Bacillus Calmette-Guerin (BCG) (Calgevax) or α-interferon. In the control group without immunotherapy (n = 16) we used conventional microlaryngeal surgery. During the follow-up, relapse occurred in two patients for the CO(2) laser surgery with Calgevax immunotherapy group (n = 16). In the group treated with α-interferon preceded by CO(2) laser surgery (n = 9) and electrosurgery (n = 2), relapse had occurred in three patients. Among the control group, recurrence was observed in six patients. This required re-operation. Our data showed a three times more frequent relapses among patients who were operated with conventional surgery as compared to those operated with CO(2) laser surgery and Calgevax immunotherapy, and two times more often relapses in patients operated with conventional surgery as compared to those with electrosurgery and CO(2) laser surgery and application of α-interferon therapy. Conventional and laser surgeries have a palliative effect, though playing an important role in ensuring the airway patency. While specific antivirus treatment for human papilloma viruses does not exist, the immune modulation with Calgevax considerably reduces the frequency of relapses, by stimulating cellular immune effector mechanisms. The combined protocol allows rarefication of relapses and improvement of patients’ quality of life, but not complete healing.
format Online
Article
Text
id pubmed-4648339
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-46483392015-12-10 Therapeutic approaches to the treatment of recurrent respiratory papillomatosis of the aerodigestive tract (a clinical study) Avramov, Toma Vetckova, Evelina Nikolova, Maria Valev, Dinko Manolova, Antoaneta Tafradgiiska, Maya Kostadinov, Dimitar Tchalacov, Ivan Biotechnol Biotechnol Equip Article; Medical Biotechnology Recurrent respiratory papillomatosis (RRP) is a rare disease, characterized by recurrent proliferation of benign squamous cell papillomas in the larynx as well as in the other parts of the aerodigestive tract. We have compared different treatment options for RRP of the aerodigestive tract including surgical, conservative and combined approaches. A total of 43 patients with papillomatosis that received a combined therapy were followed in the period from 2009 to 2013. The treatment included electrosurgery and CO(2) laser surgery alongside with either immunotherapy with Bacillus Calmette-Guerin (BCG) (Calgevax) or α-interferon. In the control group without immunotherapy (n = 16) we used conventional microlaryngeal surgery. During the follow-up, relapse occurred in two patients for the CO(2) laser surgery with Calgevax immunotherapy group (n = 16). In the group treated with α-interferon preceded by CO(2) laser surgery (n = 9) and electrosurgery (n = 2), relapse had occurred in three patients. Among the control group, recurrence was observed in six patients. This required re-operation. Our data showed a three times more frequent relapses among patients who were operated with conventional surgery as compared to those operated with CO(2) laser surgery and Calgevax immunotherapy, and two times more often relapses in patients operated with conventional surgery as compared to those with electrosurgery and CO(2) laser surgery and application of α-interferon therapy. Conventional and laser surgeries have a palliative effect, though playing an important role in ensuring the airway patency. While specific antivirus treatment for human papilloma viruses does not exist, the immune modulation with Calgevax considerably reduces the frequency of relapses, by stimulating cellular immune effector mechanisms. The combined protocol allows rarefication of relapses and improvement of patients’ quality of life, but not complete healing. Taylor & Francis 2014-07-04 2014-10-28 /pmc/articles/PMC4648339/ /pubmed/26692782 http://dx.doi.org/10.1080/13102818.2014.933500 Text en © 2014 The Author(s). Published by Taylor & Francis. http://creativecommons.org/licenses/by/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/3.0/, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
spellingShingle Article; Medical Biotechnology
Avramov, Toma
Vetckova, Evelina
Nikolova, Maria
Valev, Dinko
Manolova, Antoaneta
Tafradgiiska, Maya
Kostadinov, Dimitar
Tchalacov, Ivan
Therapeutic approaches to the treatment of recurrent respiratory papillomatosis of the aerodigestive tract (a clinical study)
title Therapeutic approaches to the treatment of recurrent respiratory papillomatosis of the aerodigestive tract (a clinical study)
title_full Therapeutic approaches to the treatment of recurrent respiratory papillomatosis of the aerodigestive tract (a clinical study)
title_fullStr Therapeutic approaches to the treatment of recurrent respiratory papillomatosis of the aerodigestive tract (a clinical study)
title_full_unstemmed Therapeutic approaches to the treatment of recurrent respiratory papillomatosis of the aerodigestive tract (a clinical study)
title_short Therapeutic approaches to the treatment of recurrent respiratory papillomatosis of the aerodigestive tract (a clinical study)
title_sort therapeutic approaches to the treatment of recurrent respiratory papillomatosis of the aerodigestive tract (a clinical study)
topic Article; Medical Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648339/
https://www.ncbi.nlm.nih.gov/pubmed/26692782
http://dx.doi.org/10.1080/13102818.2014.933500
work_keys_str_mv AT avramovtoma therapeuticapproachestothetreatmentofrecurrentrespiratorypapillomatosisoftheaerodigestivetractaclinicalstudy
AT vetckovaevelina therapeuticapproachestothetreatmentofrecurrentrespiratorypapillomatosisoftheaerodigestivetractaclinicalstudy
AT nikolovamaria therapeuticapproachestothetreatmentofrecurrentrespiratorypapillomatosisoftheaerodigestivetractaclinicalstudy
AT valevdinko therapeuticapproachestothetreatmentofrecurrentrespiratorypapillomatosisoftheaerodigestivetractaclinicalstudy
AT manolovaantoaneta therapeuticapproachestothetreatmentofrecurrentrespiratorypapillomatosisoftheaerodigestivetractaclinicalstudy
AT tafradgiiskamaya therapeuticapproachestothetreatmentofrecurrentrespiratorypapillomatosisoftheaerodigestivetractaclinicalstudy
AT kostadinovdimitar therapeuticapproachestothetreatmentofrecurrentrespiratorypapillomatosisoftheaerodigestivetractaclinicalstudy
AT tchalacovivan therapeuticapproachestothetreatmentofrecurrentrespiratorypapillomatosisoftheaerodigestivetractaclinicalstudy